HomeCompareMMIRF vs EPRT

MMIRF vs EPRT: Dividend Comparison 2026

MMIRF yields 4444.44% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MMIRF wins by $19857738408180.41M in total portfolio value
10 years
MMIRF
MMIRF
● Live price
4444.44%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19857738408180.48M
Annual income
$19,016,069,933,146,186,000.00
Full MMIRF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — MMIRF vs EPRT

📍 MMIRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMMIRFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MMIRF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MMIRF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MMIRF
Annual income on $10K today (after 15% tax)
$377,777.78/yr
After 10yr DRIP, annual income (after tax)
$16,163,659,443,174,257,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, MMIRF beats the other by $16,163,659,443,174,246,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MMIRF + EPRT for your $10,000?

MMIRF: 50%EPRT: 50%
100% EPRT50/50100% MMIRF
Portfolio after 10yr
$9928869204090.27M
Annual income
$9,508,034,966,573,100,000.00/yr
Blended yield
95.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

MMIRF
No analyst data
Altman Z
-50.9
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MMIRF buys
0
EPRT buys
0
No recent congressional trades found for MMIRF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMMIRFEPRT
Forward yield4444.44%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$19857738408180.48M$64.3K
Annual income after 10y$19,016,069,933,146,186,000.00$13,170.85
Total dividends collected$19800558376185.16M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MMIRF vs EPRT ($10,000, DRIP)

YearMMIRF PortfolioMMIRF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$455,144$444,444.44$11,212$512.01+$443.9KMMIRF
2$19,392,277$18,905,272.87$12,689$692.09+$19.38MMMIRF
3$773,548,232$752,798,494.96$14,521$944.30+$773.53MMMIRF
4$28,891,953,466$28,064,256,857.57$16,841$1,302.88+$28891.94MMMIRF
5$1,010,538,077,568$979,623,687,360.21$19,841$1,821.64+$1010538.06MMMIRF
6$33,103,483,882,921$32,022,208,139,922.89$23,818$2,587.47+$33103483.86MMMIRF
7$1,015,787,352,937,823$980,366,625,183,097.90$29,230$3,744.65+$1015787352.91MMMIRF
8$29,201,617,438,828,424$28,114,724,971,184,950.00$36,816$5,540.38+$29201617438.79MMMIRF
9$786,606,051,433,916,900$755,360,320,774,370,600.00$47,806$8,413.17+$786606051433.87MMMIRF
10$19,857,738,408,180,478,000$19,016,069,933,146,186,000.00$64,324$13,170.85+$19857738408180.41MMMIRF

MMIRF vs EPRT: Complete Analysis 2026

MMIRFStock

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. In addition, the company offers VYRA CoV2 that detects antigens specific for the nucleocapsid region of SARS-CoV-2; VYRA CoV2Flu, a combination viral nucleocapsid antigen tests that detects infection caused by SARS-CoV-2, and Influenza A and Influenza B; and REVEALCOVID-19, an antibody test. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Full MMIRF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this MMIRF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MMIRF vs SCHDMMIRF vs JEPIMMIRF vs OMMIRF vs KOMMIRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.